Search research articles
Contact Us
Filters
Showing results (161-170 of 172) with videos related to
Page
of 18
Sort By:
Journal of Medicinal Chemistry
|
March 1, 1991
Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics
P D Williams, D S Perlow, L S Payne, et al.
Journal of Medicinal Chemistry
|
November 10, 1995
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist
P D Williams, B V Clineschmidt, J M Erb, et al.
Journal of Medicinal Chemistry
|
October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product
P D Williams, M G Bock, R D Tung, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
May 3, 2025
Response to Comment on: A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial
J N Schulz, K H McGee, M T Weaver, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Design of renin inhibitors containing conformationally restricted mimetics of the P1-P1' and P1 through P2' sites
P D Williams, L S Payne, D S Perlow, et al.
Journal of Medicinal Chemistry
|
December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonists
B E Evans, G F Lundell, K F Gilbert, et al.
European Journal of Pharmacology
|
April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonist
D J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry
|
July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications
R M Freidinger, P D Williams, R D Tung, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminus
M S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2000
Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors
C A Coburn, D M Rush, P D Williams, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 172) with videos related to
Sort By:
Page
of 18
Journal of Medicinal Chemistry
|
March 1, 1991
Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics
P D Williams, D S Perlow, L S Payne, et al.
Journal of Medicinal Chemistry
|
November 10, 1995
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist
P D Williams, B V Clineschmidt, J M Erb, et al.
Journal of Medicinal Chemistry
|
October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product
P D Williams, M G Bock, R D Tung, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
May 3, 2025
Response to Comment on: A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial
J N Schulz, K H McGee, M T Weaver, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1991
Design of renin inhibitors containing conformationally restricted mimetics of the P1-P1' and P1 through P2' sites
P D Williams, L S Payne, D S Perlow, et al.
Journal of Medicinal Chemistry
|
December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonists
B E Evans, G F Lundell, K F Gilbert, et al.
European Journal of Pharmacology
|
April 24, 1991
Bradykinin agonist activity of a novel, potent oxytocin antagonist
D J Pettibone, B V Clineschmidt, E V Lis, et al.
Journal of Medicinal Chemistry
|
July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications
R M Freidinger, P D Williams, R D Tung, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminus
M S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 8, 2000
Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors
C A Coburn, D M Rush, P D Williams, et al.
Page
of 18